Discovery of Newer Therapeutic Leads for Prostate Cancer

Abstract

For many prostate cancer patients currently available drugs do not stop the lethal progression of the disease. There is a critical need for more effective therapies for the treatment of late-stage, metastatic prostate cancer. We will test the hypothesis that new drugs and/or drug leads for the treatment for metastatic prostate cancer can be identified from the understudied plants of Texas. In this effort we will prioritize the most promising plant extracts and then prepare large-scale quantities of the plant extracts using supercritical fluid extraction techniques and use this material for bioassay-guided fractionation of the biologically active constituents using modern chromatography techniques. The chemical structures of isolated compounds will be determined using NMR spectroscopy. Detailed biological evaluations will be conducted on compounds isolated.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2009
Accession Number
ADA517984

Entities

People

  • Susan L. Mooberry

Organizations

  • University of Texas Health Science Center at San Antonio

Tags

DTIC Thesaurus Topics

  • Assays
  • Bioassay
  • Biomedical Research
  • Cell Line
  • Cells
  • Chemistry
  • Diseases And Disorders
  • Extraction
  • Fractionation
  • Literature
  • Materials
  • Neoplasms
  • Plant Extracts
  • Prostate
  • Prostate Cancer
  • Test And Evaluation

Readers

  • Analytical Chemistry
  • Energy Conservation and Renewable Energy Engineering.
  • Prostate Cancer Biology.